BIOS — Bioservo Technologies AB Share Price
Last trade - 00:00- SEK94.79m
- SEK56.15m
- SEK7.10m
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.87 | ||
| Price to Tang. Book | 2.19 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 11.1 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -74.33% | ||
| Return on Equity | -72.72% | ||
| Operating Margin | -442.87% | ||
Financial Summary
| Year End 31st Dec | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 4.67 | 6.71 | 9.27 | 11.66 | 7.1 | 21 | 44 | 13.58% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health Trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Bioservo Technologies AB is a Sweden-based company within wearable technologies based on bionic soft robotics. It is engaged in developing, producing and selling muscle strengthening equipment based on the patented SEM Technology (Soft Extra Muscle Technology). The technology implies so called intention detection logic that activates the support if the wearer initiates movement with a natural and intuitive movement. This is achieved by sensors that detect the user’s action and strengthens this action by activating the motors. Its main product is a SEM Glove. The products are designed for people that have an impaired grip strength caused by injured nerves, weakening in the muscles or pain in the muscles/muscular attachments. The product is applicable in the healthcare and industry sectors.
Directors
- Anders Lundmark CHM (63)
- Petter Backgren CEO
- Madeleine Borjesson CFO
- Mattias Jamtin DSL
- Mikael Wester DMK
- Anett Grusser-Pettersson OTH
- Johan Ingvast OTH
- Laurent Krummenacher OTH
- Peter Lowendahl OTH
- Martin Wahlstedt OTH
- Runar Bjorklund DRC (61)
- Kunal Pandit DRC (40)
- Carin Ruiz DRC
- Nikolaj Soerensen DRC
- Hans von Holst IND (71)
- Last Annual
- December 31st, 2021
- Last Interim
- March 31st, 2022
- Incorporated
- October 23rd, 2003
- Public Since
- May 22nd, 2017
- No. of Employees
- 28
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 18,957,985
- Address
- Torshamnsgatan 35, KISTA, 164 40
- Web
- https://www.bioservo.com/
- Phone
- +46 8211710
- Auditors
- Praxity
Upcoming Events for BIOS
Similar to BIOS
Acarix AB
OMX Nordic Exchange Stockholm
AdderaCare AB
OMX Nordic Exchange Stockholm
Aegirbio AB
OMX Nordic Exchange Stockholm
Arcoma AB
OMX Nordic Exchange Stockholm
Arjo AB (publ)
OMX Nordic Exchange Stockholm
FAQ
As of Today at 13:03 UTC, shares in Bioservo Technologies AB are trading at SEK5.00. This share price information is delayed by 15 minutes.
Shares in Bioservo Technologies AB last closed at SEK5.00 and the price had moved by -62.46% over the past 365 days. In terms of relative price strength the Bioservo Technologies AB share price has underperformed the FTSE Global All Cap Index by -58.74% over the past year.
There is no consensus recommendation for this security.
Bioservo Technologies AB does not currently pay a dividend.
Bioservo Technologies AB does not currently pay a dividend.
Bioservo Technologies AB does not currently pay a dividend.
To buy shares in Bioservo Technologies AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK5.00, shares in Bioservo Technologies AB had a market capitalisation of SEK94.79m.
Here are the trading details for Bioservo Technologies AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: BIOS
Based on an overall assessment of its quality, value and momentum Bioservo Technologies AB is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Bioservo Technologies AB is SEK16.00. That is 220% above the last closing price of SEK5.00.
Analysts covering Bioservo Technologies AB currently have a consensus Earnings Per Share (EPS) forecast of -SEK1.70 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bioservo Technologies AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -42.77%.
As of the last closing price of SEK5.00, shares in Bioservo Technologies AB were trading -46.91% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Bioservo Technologies AB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK5.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Bioservo Technologies AB's management team is headed by:
- Anders Lundmark - CHM
- Petter Backgren - CEO
- Madeleine Borjesson - CFO
- Mattias Jamtin - DSL
- Mikael Wester - DMK
- Anett Grusser-Pettersson - OTH
- Johan Ingvast - OTH
- Laurent Krummenacher - OTH
- Peter Lowendahl - OTH
- Martin Wahlstedt - OTH
- Runar Bjorklund - DRC
- Kunal Pandit - DRC
- Carin Ruiz - DRC
- Nikolaj Soerensen - DRC
- Hans von Holst - IND